首页> 外文期刊>Nature reviews Cancer >PROMOTING APOPTOSIS AS A STRATEGY FOR CANCER DRUG DISCOVERY
【24h】

PROMOTING APOPTOSIS AS A STRATEGY FOR CANCER DRUG DISCOVERY

机译:促进细胞凋亡作为癌症药物发现的策略

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract | Apoptosis is deregulated in many cancers, making it difficult to kill tumours. Drugs that restore the normal apoptotic pathways have the potential for effectively treating cancers that depend on aberrations of the apoptotic pathway to stay alive. Apoptosis targets that are currently being explored for cancer drug discovery include the tumour-necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors, the BCL2 family of anti-apoptotic proteins, inhibitor of apoptosis (IAP) proteins and MDM2.
机译:摘要|细胞凋亡在许多癌症中被放松调节,使其难以杀死肿瘤。恢复正常细胞凋亡途径的药物具有有效治疗依赖于细胞凋亡途径异常而存活的癌症的潜力。目前正在探索的用于癌症药物发现的凋亡靶标包括与肿瘤坏死因子(TNF)相关的凋亡诱导配体(TRAIL)受体,BCL2抗凋亡蛋白家族,凋亡抑制剂(IAP)蛋白和MDM2。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号